Evidence map›Paper›PMID 35470502›Full record

ArticlePsycho-oncology2022

Are fear of cancer recurrence and fear of progression equivalent constructs?

Daelin Coutts-Bain, Louise Sharpe, Poorva Pradhan, Hayley Russell, Lauren C Heathcote, Daniel Costa

Abstract read
In one paragraph

Article in Psycho-oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Rethinking fear of cancer recurrence/progression in the era of precision medicine: is it time to consider separating?Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Cultural adaptation and validation of the Arabic version of the Fear of Cancer Scale.International journal of nursing studies advances · 2026
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Symptom distress and fear of progression associated with quality of life in multiple myeloma patients receiving treatment.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Daelin Coutts-BainThe School of Psychology, University of Sydney, Sydney, New South Wales, Australia.
Louise SharpeThe School of Psychology, University of Sydney, Sydney, New South Wales, Australia.ORCID 0000-0002-8790-6272
Poorva PradhanThe School of Psychology, University of Sydney, Sydney, New South Wales, Australia.
Hayley RussellOvarian Cancer Australia, Melbourne, Victoria, Australia.
Lauren C HeathcoteInstitute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
Daniel CostaThe School of Psychology, University of Sydney, Sydney, New South Wales, Australia.ORCID 0000-0002-6111-0620

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe predominant definition of fear of cancer recurrence (FCR) conflates FCR with fear of progression (FOP). However, this assumption has never been tested. Importantly, if FCR and FOP are distinct and have different predictors, existing interventions for FCR may not be equally effective for survivors who fear progression rather than recurrence of their disease. The present study aimed to determine whether FCR and FOP are empirically equivalent; and whether they are predicted by the same theoretically derived variables.

methodsThree hundred and eleven adults with a history of breast or ovarian cancer were analysed (n = 209, 67% in remission). Exploratory factor analysis was conducted on the items of the FCR Inventory severity subscale and short-form FOP Questionnaire together. Structural equation modelling was conducted to predict FCR and FOP and determine whether theoretical models accounted equally well for both constructs, and whether models were equally relevant to those with and without current disease.

findingsThe factor analysis demonstrated that the FCR Inventory severity subscale and the short-form FOP Questionnaire loaded onto distinct, but related, factors which represented FCR and FOP. Structural modelling indicated that risk perception and bodily threat monitoring were more strongly associated with FCR than FOP. However, both FCR and FOP were associated with metacognitions and intrusions.

interpretationThese findings suggest that whilst FCR and FOP are related with some overlapping predictors, they are not the same construct. Hence, it is necessary to ensure that in clinical practice and research these constructs are considered separately.

Indexed as

Neoplasm Recurrence, LocalPhobic DisordersAdultFearHumansSurvivorsbreast cancercancercognitionfear of cancer recurrencefear of progressionintrusionsmetacognitionsoncologyovarian cancerperceived risksurvivorship

Identifiers

PMID35470502
PMCPMC9545421

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.